시장보고서
상품코드
1181118

세계의 PoC(Point of Care) 진단 시장 분석(2023-2033년)

Point of Care Diagnostics Market Report 2023-2033

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 352 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 PoC(Point of Care) 진단 시장 규모는 2033년까지 8.8%의 CAGR로 성장할 것으로 예측되고 있습니다.

세계의 PoC 진단 시장을 분석했으며, 제품의 개요 및 시장의 기본 구조·최신 상황, 주요 촉진·억제요인, 시장 규모 추산·예측(2023-2033년), 제품별·모드별·표본별·플랫폼별·최종사용자별 및 지역별·주요 국가의 상세 동향, 주요 기업의 개요, COVID-19의 영향과 회복 시나리오 등의 정보를 정리하여 전해드립니다.

목차

제1장 분석 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 분석 결과
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 시장 기회
  • 신종 코로나바이러스 감염증(COVID-19)의 영향 분석
  • Porter's Five Forces 분석
  • PEST 분석
  • SWOT 분석

제4장 PoC 진단 시장 : 제품별(2023-2033년)

  • 주요 분석 결과
  • 시장 매력 지수 : 제품별
  • 시장 규모 추정·예측 : 제품별
  • 혈당 모니터링
    • 시장 규모 : 지역별(단위 : 10억 달러, 2023-2033년)
    • 시장 점유율 : 지역별(2023년·2033년)
  • 심장 대사 모니터링
  • 감염증 검사
  • 응고 모니터링
  • 임신·불임 검사
  • 종양·암마커 검사
  • 요검사
  • 콜레스테롤 검사
  • 혈액검사
  • 남용 약물(DOA) 검사
  • 분변잠혈 검사
  • 기타 POC 제품

제5장 PoC 진단 시장 : 모드별(2023-2033년)

  • 주요 분석 결과
  • 시장 매력 지수 : 모드별
  • 시장 규모 추정·예측 : 모드별
  • 처방전 기반 제품
  • 점포 판매(OTC) 상품

제6장 PoC 진단 시장 : 표본별(2023-2033년)

  • 주요 분석 결과
  • 시장 매력 지수 : 표본별
  • 시장 규모 추정·예측 : 표본별
  • 혈액
  • 비강·구인두 스왑
  • 기타

제7장 PoC 진단 시장 : 플랫폼별(2023-2033년)

  • 주요 분석 결과
  • 시장 매력 지수 : 플랫폼별
  • 시장 규모 추정·예측 : 플랫폼별
  • 측방유동 어세이
  • 딥스틱
  • 마이크로플루이딕스
  • 분자진단
  • 면역분석법

제8장 PoC 진단 시장 : 최종사용자별(2023-2033년)

  • 주요 분석 결과
  • 시장 매력 지수 : 최종사용자별
  • 시장 규모 추정·예측 : 최종사용자별
  • 진료소
  • 병원
  • 재택의료
  • 기타 최종사용자

제9장 PoC 진단 시장 : 지역별(2023-2033년)

  • 주요 분석 결과
  • 시장 규모 추정·예측 : 지역별

제10장 북미의 PoC 진단 시장(2023-2033년)

  • 주요 분석 결과
  • 북미의 PoC 진단 시장 매력도 지수
  • 북미의 PoC 진단 시장 : 국가별(단위 : 10억 달러, 2023년·2028년·2033년)
  • 북미 시장 추정·예측 : 제품별
  • 북미 시장 추정·예측 : 모드별
  • 북미 시장 추정·예측 : 표본별
  • 북미 시장 추정·예측 : 플랫폼별
  • 북미 시장 추정·예측 : 최종사용자별
  • 북미 시장 추정·예측 : 국가별
  • 미국 시장 분석
  • 캐나다 시장 분석

제11장 유럽의 PoC 진단 시장(2023-2033년)

  • 주요 분석 결과
  • 유럽의 PoC 진단 시장 매력도 지수
  • 유럽의 PoC 진단 시장 : 국가별(단위 : 10억 달러, 2023년·2028년·2033년)
  • 유럽 시장 추정·예측 : 국가별
  • 유럽 시장 추정·예측 : 제품별
  • 유럽 시장 추정·예측 : 모드별
  • 유럽 시장 추정·예측 : 표본별
  • 유럽 시장 추정·예측 : 플랫폼별
  • 유럽 시장 추정·예측 : 최종사용자별
  • 독일 시장 분석
  • 영국 시장 분석
  • 프랑스 시장 분석
  • 이탈리아 시장 분석
  • 스페인 시장 분석
  • 네덜란드 시장 분석
  • 기타 유럽 국가의 시장 분석

제12장 아시아태평양의 PoC 진단 시장(2023-2033년)

  • 주요 분석 결과
  • 아시아태평양의 PoC 진단 시장 매력도 지수
  • 아시아태평양의 PoC 진단 시장 : 국가별(단위 : 10억 달러, 2023년·2028년·2033년)
  • 아시아태평양 시장 추정·예측 : 국가별
  • 아시아태평양 시장 추정·예측 : 제품별
  • 아시아태평양 시장 추정·예측 : 모드별
  • 아시아태평양 시장 추정·예측 : 표본별
  • 아시아태평양 시장 추정·예측 : 플랫폼별
  • 아시아태평양 시장 추정·예측 : 최종사용자별
  • 일본 시장 분석
  • 중국 시장 분석
  • 인도 시장 분석
  • 호주 시장 분석
  • 한국 시장 분석
  • 기타 아시아태평양 국가의 시장 분석

제13장 라틴아메리카의 PoC 진단 시장(2023-2033년)

  • 주요 분석 결과
  • 라틴아메리카의 PoC 진단 시장 매력도 지수
  • 라틴아메리카의 PoC 진단 시장 : 국가별(단위 : 10억 달러, 2023년·2028년·2033년)
  • 라틴아메리카 시장 추정·예측 : 국가별
  • 라틴아메리카 시장 추정·예측 : 제품별
  • 라틴아메리카 시장 추정·예측 : 모드별
  • 라틴아메리카 시장 추정·예측 : 표본별
  • 라틴아메리카 시장 추정·예측 : 플랫폼별
  • 라틴아메리카 시장 추정·예측 : 최종사용자별
  • 브라질 시장 분석
  • 멕시코 시장 분석
  • 기타 라틴아메리카 국가의 시장 분석

제14장 중동·아프리카의 PoC 진단 시장(2023-2033년)

  • 주요 분석 결과
  • 중동·아프리카의 PoC 진단 시장 매력도 지수
  • 중동·아프리카의 PoC 진단 시장 : 국가별(단위 : 10억 달러, 2023년·2028년·2033년)
  • 중동·아프리카 시장 추정·예측 : 국가별
  • 중동·아프리카 시장 추정·예측 : 제품별
  • 중동·아프리카 시장 추정·예측 : 모드별
  • 중동·아프리카 시장 추정·예측 : 표본별
  • 중동·아프리카 시장 추정·예측 : 플랫폼별
  • 중동·아프리카 시장 추정·예측 : 최종사용자별
  • 걸프협력회의(GCC) 국가의 시장 분석
  • 남아프리카공화국 시장 분석
  • 기타 중동·아프리카 국가의 시장 분석

제15장 기업 개요

  • 경쟁 구도(2021년)
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • AccuBioTech Co., Ltd
  • Thermo Fisher Scientific
  • BD
  • Danaher
  • PTS Diagnostics
  • Trinity Biotech Ireland
  • Siemens Healthcare GmbH
  • Sekisui Diagnostics
  • Fluxergy
  • Chembio Diagnostics Inc.
  • Werfen
  • NOVA BIOMEDICAL
  • Qiagen
  • bioMerieux SA
  • Nipro Europe Group Companies
  • EKF Diagnostics Holdings plc
  • TRIVIDIA HEALTH, INC.
  • Spectral Medical Inc.
  • Orasure Technologies, Inc.
  • Response Biomedical
  • LumiraDX
  • Meridian Bioscience Inc.

제16장 결론과 제안

KSA 23.01.20

The global Point of Care Diagnostics market is projected to grow at a CAGR of 8.8% by 2033.

“The Point of Care Diagnostics Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Incidence of Target Conditions and Rising Number of CLIA Waived POC Tests Are Driving the Market Growth

Target conditions for POC testing are illnesses or disorders that require ongoing monitoring, such as diabetes, hemophilia, cancer, and cardiac problems. The adoption of POC testing equipment can therefore be attributed in large part to the rising incidence and prevalence of these illnesses. Diabetes is a serious, chronic disorder that can significantly affect people's lives, wellbeing, and families all around the world. According to IDF, in 2021, there were 537 million diabetics worldwide between the ages of 20 and 79.

CLIA defines waived tests as straightforward laboratory investigations and procedures with a very low chance of producing an erroneous result. In addition to approving manufacturer petitions for test system waivers, the Food and Drug Administration (FDA) determines what standards testing must follow in terms of being simple and error prone. The Binx health io CT/NG test, a molecular platform used to detect STDs such as chlamydia and gonorrhea at the point of treatment, acquired a CLIA waiver from the US FDA in April 2021, according to a statement released at the time

Stringent and Time-Consuming Regulatory Policies Likely to Challenge Market Growth

The complicated FDA regulations and CLIA laboratory standards present manufacturers with some regulatory challenges despite the rising demand for POC equipment (for the premarket approval of POC testing kits). Manufacturers must provide performance data to the FDA for any new POC equipment to be approved in the United States. This should show that people and healthcare professionals can use these tools and get outcomes that are comparable to those of clinical laboratory tests. For in vitro diagnostic (IVD) equipment as opposed to non-IVD ones, the amount of examination is also rather exceptional. For instance, the FDA typically waits until the intended application, conditions for usage, target patient demographic, and test performance characteristics remain intact before re-examining approved prescription non-IVD devices for use in new situations. Though under this rule POC devices are not covered.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the point of care diagnostics market evolving?
  • What is driving and restraining the point of care diagnostics market?
  • How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each point of care diagnostics submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading point of care diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the point of care diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of point of care diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the point of care diagnostics market?
  • Where is the point of care diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the point of care diagnostics market today, and over the next 10 years:

  • Our 352-page report provides 158 tables, 225 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the point of care diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising point of care diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product

  • Glucose Monitoring
  • Cardiometabolic Monitoring
  • Infectious Disease Testing
  • Coagulation Monitoring
  • Pregnancy & Fertility Testing
  • Tumor/Cancer Marker Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Hematology Testing
  • Drugs-of-abuse Testing
  • Fecal Occult Testing
  • Other POC Products

Mode

  • Prescription-based
  • OTC

Sample

  • Blood
  • Nasal and Oropharyngeal Swabs
  • Urine
  • Other

Platform

  • Lateral Flow Assay
  • Dipstick
  • Microfluidics
  • Molecular diagnostics
  • Immunoassay

End User

  • Clinics
  • Hospitals
  • Home Care Setting
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Point of Care Diagnostics Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Abbott
  • AccuBioTech Co., Ltd
  • BD
  • bioMerieux SA
  • Chembio Diagnostics, Inc.
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • Fluxergy
  • LumiraDx
  • Meridian Bioscience
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Orasure Technologies, Inc.
  • PTS Diagnostics
  • Qiagen
  • Quidel Corporation
  • Response Biomedical
  • Sekisui Diagnostics
  • Siemens Healthcare GmbH
  • Spectral Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Ireland
  • Trividia Health, Inc.
  • Werfen

Overall world revenue for Point of Care Diagnostics Market, 2023 to 2033 in terms of value the market will surpass US$43 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Point of care diagnostics Market, 2023 to 2033 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Point of Care Diagnostics Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Point of Care Diagnostics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Netherlands, China, India, Japan, Australia, South Korea, Brazil, GCC, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Point of Care Diagnostics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Point of Care Diagnostics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Point of Care Diagnostics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 High Prevalence of Infectious Diseases Across the Globe
      • 3.2.1.2 Increasing Incidence of Target Conditions
      • 3.2.1.3 Growing Government Support
      • 3.2.1.4 Rising Number of CLIA Waived POC Tests
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
      • 3.2.2.2 Stringent and Time-Consuming Regulatory Policies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 POC Tests with Multiplexing Capabilities
      • 3.2.3.2 Healthcare Decentralization - Converting Lab Tests to POC Tests
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Low Bargaining Power of Supplier
    • 3.4.2 High Bargaining Power of Buyer
    • 3.4.3 Low Threat of New Entrants
    • 3.4.4 High Threat of Substitutes
    • 3.4.5 High Intensity of Competitive Rivalry
  • 3.5 PEST Analysis
  • 3.6 SWOT Analysis

4 Point of Care Diagnostics Market, by Product, 2023-2033

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 4.4 Glucose Monitoring
    • 4.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Cardiometabolic Monitoring
    • 4.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Infectious Disease Testing
    • 4.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.7 Coagulation Monitoring
    • 4.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.8 Pregnancy & Fertility Testing
    • 4.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.8.2 Market Share by Region, 2023 & 2033 (%)
  • 4.9 Tumour/Cancer Marker Testing
    • 4.9.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.9.2 Market Share by Region, 2023 & 2033 (%)
  • 4.10 Urinalysis Testing
    • 4.10.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.10.2 Market Share by Region, 2023 & 2033 (%)
  • 4.11 Cholesterol Testing
    • 4.11.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.11.2 Market Share by Region, 2023 & 2033 (%)
  • 4.12 Hematology Testing
    • 4.12.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.12.2 Market Share by Region, 2023 & 2033 (%)
  • 4.13 Drugs-of-abuse Testing
    • 4.13.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.13.2 Market Share by Region, 2023 & 2033 (%)
  • 4.14 Fecal Occult Testing
    • 4.14.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.14.2 Market Share by Region, 2023 & 2033 (%)
  • 4.15 Other POC Products
    • 4.15.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.15.2 Market Share by Region, 2023 & 2033 (%)

5 Point of Care Diagnostics Market, by Mode, 2023-2033

  • 5.1 Key Findings
  • 5.2 Mode Segment: Market Attractiveness Index
  • 5.3 Point of Care Diagnostics Market, by Mode
  • 5.4 Prescription-based Products
    • 5.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Over the Counter (OTC) Products
    • 5.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Point of Care Diagnostics Market, by Sample, 2023-2033

  • 6.1 Key Findings
  • 6.2 Sample Segment: Market Attractiveness Index
  • 6.3 Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 6.4 Blood
    • 6.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Nasal and Oropharyngeal Swabs
    • 6.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Urine
    • 6.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Other
    • 6.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Point of Care Diagnostics Market, by Platform, 2023-2033

  • 7.1 Key Findings
  • 7.2 Platform Segment: Market Attractiveness Index
  • 7.3 Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 7.4 Lateral Flow Assay
    • 7.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Dipstick
    • 7.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Microfluidics
    • 7.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Molecular diagnostics
    • 7.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Immunoassay
    • 7.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Point of Care Diagnostics Market, by End User, 2023-2033

  • 8.1 Key Findings
  • 8.2 End User Segment Market Attractiveness Index
  • 8.3 Point of Care Diagnostics Market Size Estimation and Forecast by End User
  • 8.4 Clinics
    • 8.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Hospitals
    • 8.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Home Care Settings
    • 8.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Other End-users
    • 8.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)

9 Point of Care Diagnostics Market Analysis by Region, 2023-2033

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Point of Care Diagnostics Market, 2023-2033

  • 10.1 Key Findings
  • 10.2 North America Point of Care Diagnostics Market Attractiveness Index
  • 10.3 North America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 10.4 North America Point of Care Diagnostics Market Forecast by Product
  • 10.5 North America Point of Care Diagnostics Market Forecast by Mode
  • 10.6 North America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 10.7 North America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 10.8 North America Point of Care Diagnostics Market Size Estimation and Forecast by End Users
  • 10.9 North America Point of Care Diagnostics Market Forecast by Country
  • 10.10 U.S. Point of Care Diagnostics Market Analysis
  • 10.11 Canada Point of Care Diagnostics Market Analysis

11 Europe Point of Care Diagnostics Market, 2023-2033

  • 11.1 Key Findings
  • 11.2 Europe Point of Care Diagnostics Market Attractiveness Index
  • 11.3 Europe Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 11.4 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 11.5 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 11.6 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 11.7 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 11.8 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 11.9 Europe Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 11.10 Germany Point of Care Diagnostics Market Analysis
  • 11.11 UK Point of Care Diagnostics Market Analysis
  • 11.12 France Point of Care Diagnostics Market Analysis
  • 11.13 Italy Point of Care Diagnostics Market Analysis
  • 11.14 Spain Point of Care Diagnostics Market Analysis
  • 11.15 Netherlands Point of Care Diagnostics Market Analysis
  • 11.16 Rest of Europe Point of Care Diagnostics Market Analysis

12 Asia Pacific Point of Care Diagnostics Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Pacific Point of Care Diagnostics Market Attractiveness Index
  • 12.3 Asia Pacific Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 12.6 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 12.7 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 12.8 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 12.9 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 12.10 Japan Point of Care Diagnostics Market Analysis
  • 12.11 China Point of Care Diagnostics Market Analysis
  • 12.12 India Point of Care Diagnostics Market Analysis
  • 12.13 Australia Point of Care Diagnostics Market Analysis
  • 12.14 South Korea Point of Care Diagnostics Market Analysis
  • 12.15 Rest of Asia Pacific Point of Care Diagnostics Market Analysis

13 Latin America Point of Care Diagnostics Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Point of Care Diagnostics Market Attractiveness Index
  • 13.3 Latin America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 13.4 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 13.5 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 13.6 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 13.7 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 13.8 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 13.9 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 13.10 Brazil Point of Care Diagnostics Market Analysis
  • 13.11 Mexico Point of Care Diagnostics Market Analysis
  • 13.12 Rest of Latin America Point of Care Diagnostics Market Analysis

14 MEA Point of Care Diagnostics Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Point of Care Diagnostics Market Attractiveness Index
  • 14.3 MEA Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 14.4 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 14.5 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 14.6 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 14.7 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 14.8 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 14.9 MEA Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 14.10 GCC Point of Care Diagnostics Market Analysis
  • 14.11 South Africa Point of Care Diagnostics Market Analysis
  • 14.12 Rest of MEA Point of Care Diagnostics Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2021
  • 15.2 Abbott
    • 15.2.1 Company Snapshot
    • 15.2.2 Company Overview
    • 15.2.3 Financial Analysis
      • 15.2.3.1 Net Revenue, 2017-2021
      • 15.2.3.2 R&D, 2017-2021
      • 15.2.3.3 Regional Market Shares, 2021
    • 15.2.4 Product Benchmarking
    • 15.2.5 Strategic Outlook
  • 15.3 F. Hoffmann-La Roche Ltd
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2021
      • 15.3.3.2 R&D, 2017-2021
      • 15.3.3.3 Regional Market Shares, 2021
    • 15.3.4 Product Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 Quidel Corporation
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2021
      • 15.4.3.2 R&D, 2017-2021
      • 15.4.3.3 Regional Market Shares, 2021
    • 15.4.4 Product Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 AccuBioTech Co., Ltd
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Product Benchmarking
    • 15.5.4 Strategic Outlook
  • 15.6 Thermo Fisher Scientific
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2021
      • 15.6.3.2 R&D, 2017-2021
    • 15.6.4 Product Benchmarking
    • 15.6.5 Strategic Outlook
  • 15.7 BD
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2021
      • 15.7.3.2 R & D, 2017-2021
      • 15.7.3.3 Regional Market Shares, 2021
    • 15.7.4 Product Benchmarking
    • 15.7.5 Strategic Outlook
  • 15.8 Danaher
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2021
      • 15.8.3.2 R&D, 2017-2021
      • 15.8.3.3 Regional Market Shares, 2021
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 PTS Diagnostics
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Product Benchmarking
  • 15.10 Trinity Biotech Ireland
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2021
      • 15.10.3.2 Regional Market Shares, 2021
    • 15.10.4 Product Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 Siemens Healthcare GmbH
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Financial Analysis
      • 15.11.3.1 Net Revenue, 2017-2021
      • 15.11.3.2 R&D, 2017-2021
      • 15.11.3.3 Regional Market Shares, 2021
    • 15.11.4 Product Benchmarking
    • 15.11.5 Strategic Outlook
  • 15.12 Sekisui Diagnostics
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Product Benchmarking
    • 15.12.4 Strategic Outlook
  • 15.13 Fluxergy
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Product Benchmarking
    • 15.13.4 Strategic Outlook
  • 15.14 Chembio Diagnostics Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Financial Analysis
      • 15.14.3.1 Net Revenue, 2017-2021
      • 15.14.3.2 R&D, 2017-2021
      • 15.14.3.3 Regional Market Shares, 2021
    • 15.14.4 Product Benchmarking
    • 15.14.5 Strategic Outlook
  • 15.15 Werfen
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Financial Analysis
      • 15.15.3.1 Net Revenue, 2017-2021
      • 15.15.3.2 R&D, 2017-2021
      • 15.15.3.3 Regional Market Shares, 2021
    • 15.15.4 Product Benchmarking
  • 15.16 NOVA BIOMEDICAL
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Product Benchmarking
  • 15.17 Qiagen
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2017-2021
      • 15.17.3.2 R&D, 2017-2021
      • 15.17.3.3 Regional Market Shares, 2021
    • 15.17.4 Product Benchmarking
    • 15.17.5 Strategic Outlook
  • 15.18 bioMerieux SA
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Financial Analysis
      • 15.18.3.1 Net Revenue, 2017-2021
      • 15.18.3.2 R&D, 2017-2021
      • 15.18.3.3 Regional Market Shares, 2021
    • 15.18.4 Product Benchmarking
    • 15.18.5 Strategic Outlook
  • 15.19 Nipro Europe Group Companies
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Financial Analysis
      • 15.19.3.1 Net Revenue, 2017-2021
      • 15.19.3.2 R&D, 2017-2021
      • 15.19.3.3 Regional Market Shares, 2021
    • 15.19.4 Product Benchmarking
    • 15.19.5 Strategic Outlook
  • 15.20 EKF Diagnostics Holdings plc
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Financial Analysis
      • 15.20.3.1 Net Revenue, 2017-2021
      • 15.20.3.2 Regional Market Shares, 2021
    • 15.20.4 Product Benchmarking
    • 15.20.5 Strategic Outlook
  • 15.21 TRIVIDIA HEALTH, INC.
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Product Benchmarking
  • 15.22 Spectral Medical Inc.
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Product Benchmarking
  • 15.23 Orasure Technologies, Inc.
    • 15.23.1 Company Snapshot
    • 15.23.2 Company Overview
    • 15.23.3 Financial Analysis
      • 15.23.3.1 Net Revenue, 2017-2021
      • 15.23.3.2 R&D, 2017-2021
      • 15.23.3.3 Regional Market Shares, 2021
    • 15.23.4 Product Benchmarking
    • 15.23.5 Strategic Outlook
  • 15.24 Response Biomedical
    • 15.24.1 Company Snapshot
    • 15.24.2 Company Overview
    • 15.24.3 Product Benchmarking
    • 15.24.4 Strategic Outlook
  • 15.25 LumiraDX
    • 15.25.1 Company Snapshot
    • 15.25.2 Company Overview
    • 15.25.3 Financial Analysis
      • 15.25.3.1 Net Revenue, 2019-2021
      • 15.25.3.2 R&D, 2019-2021
    • 15.25.4 Product Benchmarking
    • 15.25.5 Strategic Outlook
  • 15.26 Meridian Bioscience Inc.
    • 15.26.1 Company Snapshot
    • 15.26.2 Company Overview
    • 15.26.3 Financial Analysis
      • 15.26.3.1 Net Revenue, 2017-2021
      • 15.26.3.2 R&D, 2017-2021
      • 15.26.3.3 Regional Market Shares, 2021
    • 15.26.4 Product Benchmarking
    • 15.26.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from
  • 16.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제